Semoran Medical Arts Building is categorized under Health Services in Casselberry, FL and active since 2001.
Semoran Medical Arts Building was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact George Cestaro at the company’s single location by writing to 515 State Road 436 # 1000, Casselberry, Florida FL 32707 or by phoning (407) 365-3775. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Semoran Medical Arts Building |
| Contact Person: | George Cestaro |
| Address: | 515 State Road 436 # 1000, Casselberry, Florida 32707 |
| Phone Number: | (407) 365-3775 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Semoran Medical Arts Building was started in 2001 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact George Cestaro for inquiries that concern Semoran Medical Arts Building by calling the company number (407) 365-3775, as your correspondence is most welcome. Additionally, the physical location of the single location of Semoran Medical Arts Building can be found at the coordinates 28.654026,-81.33189 as well as the street address 515 State Road 436 # 1000 in Casselberry, Florida 32707.
For its online presence, you may visit Semoran Medical Arts Building’s website at and engage with its social media outlets through on Twitter and on Facebook.